Page 587 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )
P. 587

CHAPTER 28  ■  Disorders of Hemostasis and Thrombosis: Blood Coagulation Factors, Hypercoagulable State, and Anticoagulant Therapy                                                                 571






                                                                                                                                PAI-1
                                                                                                                                                           Plasminogen



                                                                                                         tPA
                                                                                                         uPA


                                                                                                                                                                                          α AP
                                                                                                                                                                                            2
                                                                                                                                                                                           α M
                                                                                                                                                                                             2


                                                                                                                                                              Plasmin
                                                                                                Endothelial cells





                                                                               Xa/Va                                                                      Fibrin                        D-Dimer
                                                                                                                                                                                          FDPs


                                                  Prothrombin                                            Thrombin






                                                                                                                                                     Fibrinogen


                                                                                                  Thrombomodulin



                                                                                                                                                                            TAFIa
                                                                    aPC









                                                                Protein C                                                                            TAFI




                                     FIGURE 28.4  Fibrino ysis. T ro  bin, generate    ro     rothro  bin by the action o  the Xa/Va   rothro  binase
                                     co     ex, activates en  othe ia  ce  s to   ro  uce    as  inogen activators. T ese, in turn, c eave    as  inogen to  or

                                        as  in, which   egra  es   brin ( or  e   by the action o  thro  bin on   brinogen) to d-  i  er  rag  ents an   other

                                       brinogen   egra  ation   ro  ucts. Inhibitors o    brino ysis (in   ia  on  s) inc u  e PAI-1, which inhibits the actions

                                     o  tPA an   uPA, an   a 2AP, β 2M, an     AFI, which inhibit    as  in. T ro  bin, when boun   to thro  bo  o  u in
                                     on the sur ace o  en  othe ia  ce  s, activates   AFI to its active  or   an     ro  uces activate     rotein C, an i    ortant

                                     vita  in K–  e  en  ent   rotein with anticoagu ant an   anti-inf a    atory   ro  erties. α 2AP, a   ha-2-anti   as  in

                                     (a   ha-2-   as  in inhibitor); a 2M, a   ha-2-  acrog obu in; tPA, tissue-ty  e    as  inogen activator; uPA, urine-

                                     ty  e    as  inogen activator; PAI-1,    as  inogen activator inhibitor ty  e-1; FDPs,   brin   egra  ation   ro  ucts; Xa,
                                     activate    actor X; Va, activate    actor V; aPC, activate     rotein C;   AFI, thro  bin-activatab e   brino ysis inhibitor;

                                       AFIa, activate     AFI. (Source: Sha  ner DH, Nicho s DG. Rogers’   extbook o  Pediatric Intensive Care, Phi a  e   hia,

                                     PA: Li    incott Wi  ia  s & Wi kins, 2015.)





























































                                     FIGURE  28.5  Fibrino ysis. (Fro   Buck in BA, Baysinger CL, Ga  b ing D. A Practical Approach to Obstetric

                                     Anesthesia, 2n   e  , Phi a  e   hia, PA: Li    incott Wi  ia  s & Wi kins, 2016.)
   582   583   584   585   586   587   588   589   590   591   592